These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9868654)

  • 21. Nonadherence to oral linezolid after hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals.
    Ball AT; Xu Y; Sanchez RJ; Shelbaya A; Deminski MC; Nau DP
    Clin Ther; 2010 Dec; 32(13):2246-55. PubMed ID: 21316540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicare program; announcement of the calendar year 2002 conversion factor for the hospital outpatient prospective payment system and a pro rata reduction on transitional pass-through payments. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2001 Nov; 66(213):55857-66. PubMed ID: 11760765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V; Khachatryan A; Xue M; Dunne M; Johnson K; Stephens J
    J Med Econ; 2015; 18(12):1092-101. PubMed ID: 26368787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparing for the outpatient treatment of venous disease under MACRA.
    Leers SA; Woo K; Rathbun J; Johnson B
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):133. PubMed ID: 29248103
    [No Abstract]   [Full Text] [Related]  

  • 25. Outpatient antibiotic therapy.
    George RH
    J Antimicrob Chemother; 1985 Feb; 15(2):257-8. PubMed ID: 3980317
    [No Abstract]   [Full Text] [Related]  

  • 26. ProPAC's advice: help beneficiaries, spare providers.
    Blankenau R
    Hospitals; 1993 Feb; 67(4):60. PubMed ID: 8428744
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost issues in sequential therapy.
    Cooke J
    J Infect; 1998 Jul; 37 Suppl 1():45-50. PubMed ID: 9756369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new medicare law: drugs, outpatient therapy, new wellness benefits, and changes to your costs.
    Care Manag J; 2003; 4(4):223-8. PubMed ID: 15628657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of on-call infectious-diseases pharmacists on antibiotic expenditures.
    Scheetz MH; Postelnick MJ; Scarsi KK; Gerzenshtein L; Bolon MK; Fotis M; Noskin GA
    Am J Health Syst Pharm; 2005 Oct; 62(19):1967-8. PubMed ID: 16174825
    [No Abstract]   [Full Text] [Related]  

  • 30. Sequential antibiotic therapy: the right patient, the right time and the right outcome.
    Davey P; Nathwani D
    J Infect; 1998 Jul; 37 Suppl 1():37-44. PubMed ID: 9756368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Organ Procurement Organization Reporting and Communication; Transplant Outcome Measures and Documentation Requirements; Electronic Health Record (EHR) Incentive Programs; Payment to Nonexcepted Off-Campus Provider-Based Department of a Hospital; Hospital Value-Based Purchasing (VBP) Program; Establishment of Payment Rates Under the Medicare Physician Fee Schedule for Nonexcepted Items and Services Furnished by an Off-Campus Provider-Based Department of a Hospital. Final rule with comment period and interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(219):79562-892. PubMed ID: 27906530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of benchmarking clinical practice with the clinical laboratory. An institutional case study.
    Bissell MG
    Clin Lab Med; 1999 Dec; 19(4):867-76, vii-viii. PubMed ID: 10572720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare and graduate medical education.
    Iglehart JK
    N Engl J Med; 1998 Feb; 338(6):402-7. PubMed ID: 9449736
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicare program--prospective payment system for hospital outpatient services: criteria for establishing additional pass-through categories for medical devices. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2001 Nov; 66(213):55849-57. PubMed ID: 11760764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the new Medicare Outpatient Prospective Payment System.
    Ruiz-Law T
    AANA J; 2000 Dec; 68(6):491-5. PubMed ID: 11272955
    [No Abstract]   [Full Text] [Related]  

  • 36. Medicare program: changes to the hospital outpatient prospective payment system and CY 2010 payment rates; changes to the ambulatory surgical center payment system and CY 2010 payment rates. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2009 Nov; 74(223):60315-983. PubMed ID: 20166279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and economical efficacy of the different variants of inpatient treatment of ulcerative diseases].
    Vakhrushev IaM; Muravtseva OV
    Eksp Klin Gastroenterol; 2008; (4):28-30. PubMed ID: 19145900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicare program: hospital outpatient prospective payment system and CY 2011 payment rates; ambulatory surgical center payment system and CY 2011 payment rates; payments to hospitals for graduate medical education costs; physician self-referral rules and related changes to provider agreement regulations; payment for certified registered nurse anesthetist services furnished in rural hospitals and critical access hospitals. Final rule with comment period; final rules; and interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Nov; 75(226):71799-2580. PubMed ID: 21121180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Medicare rules for ambulatory care and APCs: data is king.
    Russ Coiles Health Trends; 2000 Jul; 12(9):1, 4-9. PubMed ID: 11183164
    [No Abstract]   [Full Text] [Related]  

  • 40. Bridging the gap: state and private industry response to the lack of a Medicare outpatient prescription drug benefit.
    Goldstein WC; Peterson KA
    Manag Care Interface; 2002 Jun; 15(6):55-8. PubMed ID: 12087608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.